These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11489488)

  • 1. Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy.
    Xu L; Pirollo KF; Chang EH
    J Control Release; 2001 Jul; 74(1-3):115-28. PubMed ID: 11489488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic p53 gene therapy of cancer with immunolipoplexes targeted by anti-transferrin receptor scFv.
    Xu L; Tang WH; Huang CC; Alexander W; Xiang LM; Pirollo KF; Rait A; Chang EH
    Mol Med; 2001 Oct; 7(10):723-34. PubMed ID: 11713371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes.
    Xu L; Huang CC; Huang W; Tang WH; Rait A; Yin YZ; Cruz I; Xiang LM; Pirollo KF; Chang EH
    Mol Cancer Ther; 2002 Mar; 1(5):337-46. PubMed ID: 12489850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts.
    Xu L; Pirollo KF; Tang WH; Rait A; Chang EH
    Hum Gene Ther; 1999 Dec; 10(18):2941-52. PubMed ID: 10609655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-targeting, systemically delivered antisense HER-2 chemosensitizes human breast cancer xenografts irrespective of HER-2 levels.
    Rait AS; Pirollo KF; Xiang L; Ulick D; Chang EH
    Mol Med; 2002 Aug; 8(8):475-86. PubMed ID: 12435858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
    Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 gene therapy of human osteosarcoma using a transferrin-modified cationic liposome.
    Nakase M; Inui M; Okumura K; Kamei T; Nakamura S; Tagawa T
    Mol Cancer Ther; 2005 Apr; 4(4):625-31. PubMed ID: 15827336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinatory anti-tumor effects of electroporation-mediated chemotherapy and wild-type p53 gene transfer to human esophageal cancer cells.
    Matsubara H; Maeda T; Gunji Y; Koide Y; Asano T; Ochiai T; Sakiyama S; Tagawa M
    Int J Oncol; 2001 Apr; 18(4):825-9. PubMed ID: 11251180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 and PTEN/MMAC1/TEP1 gene therapy of human prostate PC-3 carcinoma xenograft, using transferrin-facilitated lipofection gene delivery strategy.
    Seki M; Iwakawa J; Cheng H; Cheng PW
    Hum Gene Ther; 2002 Apr; 13(6):761-73. PubMed ID: 11936974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transferrin-liposome-mediated p53 sensitization of squamous cell carcinoma of the head and neck to radiation in vitro.
    Xu L; Pirollo KF; Chang EH
    Hum Gene Ther; 1997 Mar; 8(4):467-75. PubMed ID: 9054521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective treatment of early endobronchial cancer with regional administration of liposome-p53 complexes.
    Zou Y; Zong G; Ling YH; Hao MM; Lozano G; Hong WK; Perez-Soler R
    J Natl Cancer Inst; 1998 Aug; 90(15):1130-7. PubMed ID: 9701362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCL-2 antisense and cisplatin combination treatment of MCF-7 breast cancer cells with or without functional p53.
    Basma H; El-Refaey H; Sgagias MK; Cowan KH; Luo X; Cheng PW
    J Biomed Sci; 2005 Dec; 12(6):999-1011. PubMed ID: 16228292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor targeting using anti-her2 immunoliposomes.
    Park JW; Kirpotin DB; Hong K; Shalaby R; Shao Y; Nielsen UB; Marks JD; Papahadjopoulos D; Benz CC
    J Control Release; 2001 Jul; 74(1-3):95-113. PubMed ID: 11489487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of cationic liposome formulations for intratracheal gene therapy of early lung cancer.
    Zou Y; Zong G; Ling YH; Perez-Soler R
    Cancer Gene Ther; 2000 May; 7(5):683-96. PubMed ID: 10830716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector.
    Ramesh R; Saeki T; Templeton NS; Ji L; Stephens LC; Ito I; Wilson DR; Wu Z; Branch CD; Minna JD; Roth JA
    Mol Ther; 2001 Mar; 3(3):337-50. PubMed ID: 11273776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced p53 gene transfer to human ovarian cancer cells using the cationic nonviral vector, DDC.
    Kim CK; Choi EJ; Choi SH; Park JS; Haider KH; Ahn WS
    Gynecol Oncol; 2003 Aug; 90(2):265-72. PubMed ID: 12893186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of therapeutic nucleic acids via transferrin and transferrin receptors: lipoplexes and other carriers.
    Tros de Ilarduya C; Düzgüneş N
    Expert Opin Drug Deliv; 2013 Nov; 10(11):1583-91. PubMed ID: 24050263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 Replacement Therapy for Cancer.
    Tazawa H; Kagawa S; Fujiwara T
    Recent Results Cancer Res; 2016; 209():1-15. PubMed ID: 28101684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
    Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
    J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-assembly of a virus-mimicking nanostructure system for efficient tumor-targeted gene delivery.
    Xu L; Frederik P; Pirollo KF; Tang WH; Rait A; Xiang LM; Huang W; Cruz I; Yin Y; Chang EH
    Hum Gene Ther; 2002 Feb; 13(3):469-81. PubMed ID: 11860713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.